MedPath

Treatment of anxiety by homoeopathy

Phase 2
Completed
Conditions
Health Condition 1: F411- Generalized anxiety disorder
Registration Number
CTRI/2018/03/012685
Lead Sponsor
ational Institute of Homoeopathy Ministry of AYUSH Govt of India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
62
Inclusion Criteria

1. Cases suffering from GAD, diagnosed as per DSM-V criteria

2. Moderate to severe cases of anxiety (GAD-7 scores 10-15 and HAM-A scores 18-30)

3. Both male and female patients

4. Age between 18 and 65 years

5. Patients giving written consent to participate in the study

7. Literate patients who can read Bengali and/or English

Exclusion Criteria

1. Mild (GAD-7 < 10 and HAM-A < 18) or very severe (GAD-7 > 15 and HAM-A > 30) cases of anxiety

2. Use of psychoactive medications prior to study entry that precluded participation included depot neuroleptics within 6 months; any neuroleptic, antidepressant, or anxiolytic within 2 weeks (5 weeks for fluoxetine); daily benzodiazepine therapy within 1 month; and concomitant treatment with any psychotropic drug (except zolpidem for sleep) or any drug with a psychotropic component.

3. Patients with other psychiatric diseases.

4. Cases suffering from uncontrolled systemic illness or life-threatening infections

5. Cases already undergoing homoeopathic treatment for any chronic disease

6. Substance abuse and/or dependence

7. Pregnant women, lactating mothers, and women who are planning pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Generalized Anxiety Disorder 7 (GAD-7) questionnaire (Bengali version)Timepoint: Baseline and after 3 months
Secondary Outcome Measures
NameTimeMethod
Hamilton Anxiety Rating Scale (HAM-A)Timepoint: Baseline and after 3 months
© Copyright 2025. All Rights Reserved by MedPath